← Back to Search

Probiotic

1 for MRSA Colonization (MRSA Trial)

Phase 2
Waitlist Available
Led By Dr Pierre-Jean PM Maziade, MD
Research Sponsored by Bio-K Plus International Inc.
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up up to 5 years

Summary

Trial Objectives: Primary objective: * To evaluate the efficacy of Bio-K+CL1285® in patients with Methicillin-Resistant S. aureus (MRSA) nasal colonization by comparing the MRSA decolonization following either Bio-K+CL1285® or placebo treatment. Secondary objective: * To evaluate the safety profile of Bio-K+CL1285®.

Eligible Conditions
  • MRSA Colonization

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~up to 5 years
This trial's timeline: 3 weeks for screening, Varies for treatment, and up to 5 years for reporting.

Treatment Details

Trial Design

2Treatment groups
Experimental Treatment
Placebo Group
Group I: 1Experimental Treatment1 Intervention
Bio-K+ CL1285 contains 50 billion of live bacteria
Group II: 2Placebo Group1 Intervention
placebo devoid of bacteria

Find a Location

Who is running the clinical trial?

Bio-K Plus International Inc.Lead Sponsor
7 Previous Clinical Trials
1,451 Total Patients Enrolled
Centre Hospitalier Pierre-Le GardeurUNKNOWN
Dr Pierre-Jean PM Maziade, MDPrincipal InvestigatorPierre Le Gardeur Hospital
~0 spots leftby Nov 2025